Votrient 400mg Tablet
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Pazopanib (400mg)
Overview Votrient 400mg Tablet
Pazopanib 400mg tablets, a tyrosine kinase inhibitor, treat kidney cancer and soft-tissue sarcoma. For optimal absorption, take this medication on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your condition and may adjust over time; adhere strictly to their instructions. Incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include elevated blood pressure and diarrhea. Your doctor may recommend regular blood pressure checks. Manage diarrhea with increased fluid intake or consult your physician if it worsens. This medication can lower blood cell counts, increasing infection risk. Report fever, flu-like symptoms, or shortness of breath immediately. Inform your doctor of pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, as drug interactions are possible. Avoid pregnancy during treatment; reliable contraception is essential for both partners. A patient assistance program is available in India through Tata 1mg; contact your doctor or call (1800-102-1618) for details.
Uses of Votrient 400mg Tablet
Renal cell carcinoma and soft tissue sarcoma
Major Benefits of Votrient 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Votrient 400mg Tablet on an empty stomach.
Common Side effects of Votrient 400mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Votrient 400mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Votrient 400mg Tablet on an empty stomach.
How Votrient 400mg Tablet works:
Pazopanib 400mg tablets are a cancer treatment that functions by selectively targeting and blocking tyrosine kinase enzyme receptors, thus hindering the uncontrolled multiplication of malignant cells. The medication also suppresses angiogenesis, the formation of new blood vessels that nourish tumors, thereby limiting cancer growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Votrient 400mg tablets may pose safety risks; therefore, physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Votrient 400mg tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding while taking Votrient 400mg tablets is contraindicated due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Taking a 400mg Votrient tablet can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Pazopanib 400mg tablets are suitable for use in patients exhibiting renal impairment. No alteration of the pazopanib 400mg tablet dosage is advised.
LiverCAUTION
Patients with liver impairment should use 400mg Votrient tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Votrient 400mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Votrient 400mg Tablet :
NA
Facts to Know About Votrient 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |



